Anthera is a startup based in the United States, most recent round Series-c-plus.
Anthera is a startup based in the United States. Its most recent tracked round is Series-c-plus.
Anthera was a US drug-development company focused on cardiovascular therapeutics. The company was listed on NASDAQ in 2010.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.